These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 7474945
21. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB. Cancer Res; 1995 Nov 15; 55(22):5272-5. PubMed ID: 7585587 [Abstract] [Full Text] [Related]
22. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Martinez A, Salas E, Radomski A, Radomski MW. Med Sci Monit; 2001 Nov 15; 7(4):646-51. PubMed ID: 11433190 [Abstract] [Full Text] [Related]
24. Effects of quercetin on aggregation and intracellular free calcium of platelets. Xiao D, Gu ZL, Bai JP, Wang Z. Zhongguo Yao Li Xue Bao; 1995 May 15; 16(3):223-6. PubMed ID: 7660815 [Abstract] [Full Text] [Related]
26. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. Chou TC, Li CY, Yen MH, Ding YA. Biochem Pharmacol; 1999 Nov 15; 58(10):1657-63. PubMed ID: 10535758 [Abstract] [Full Text] [Related]
27. Oxidative stress, l-arginine-nitric oxide and arginase pathways in platelets from adolescents with anorexia nervosa. Rodrigues Pereira N, Bandeira Moss M, Assumpção CR, Cardoso CB, Mann GE, Brunini TM, Mendes-Ribeiro AC. Blood Cells Mol Dis; 2010 Mar 15; 44(3):164-8. PubMed ID: 20071203 [Abstract] [Full Text] [Related]
31. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells. Durante W, Schini VB, Scott-Burden T, Junquero DC, Kroll MH, Vanhoutte PM, Schafer AI. Am J Physiol; 1991 Dec 15; 261(6 Pt 2):H2024-30. PubMed ID: 1661096 [Abstract] [Full Text] [Related]
32. Effects of non-surgical periodontal treatment on the L-arginine-nitric oxide pathway and oxidative status in platelets. Siqueira MA, Fischer RG, Pereira NR, Martins MA, Moss MB, Mendes-Ribeiro AC, Figueredo CM, Brunini TM. Exp Biol Med (Maywood); 2013 Jun 15; 238(6):713-22. PubMed ID: 23918883 [Abstract] [Full Text] [Related]
33. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects. Mutus B, Rabini RA, Staffolani R, Ricciotti R, Fumelli P, Moretti N, Martarelli D, Mazzanti L. Diabetologia; 2001 Aug 15; 44(8):979-82. PubMed ID: 11484074 [Abstract] [Full Text] [Related]
34. Inhibition of platelet aggregation by low concentrations of sodium fluoride. Significance of the intracellular calcium ion concentration. Kondo K, Kitada C, Yoshioka A, Sakane H, Kokawa T, Yasunaga K. Int J Hematol; 1991 Oct 15; 54(5):411-7. PubMed ID: 1756251 [Abstract] [Full Text] [Related]
36. A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation. Zhou K, Li X, Du Q, Li D, Hu M, Yang X, Jiang Q, Li Z. Pharmazie; 2014 Aug 15; 69(8):615-20. PubMed ID: 25158573 [Abstract] [Full Text] [Related]
38. Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo. Apostoli GL, Solomon A, Smallwood MJ, Winyard PG, Emerson M. J Thromb Haemost; 2014 Nov 15; 12(11):1880-9. PubMed ID: 25163536 [Abstract] [Full Text] [Related]
39. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets. Nimpf J, Gries A, Wurm H, Kostner GM. Thromb Haemost; 1985 Dec 17; 54(4):824-7. PubMed ID: 3003956 [Abstract] [Full Text] [Related]